Multimodal NASH prognosis using 3D imaging flow cytometry and artificial intelligence to characterize liver cells.

Ramkumar Subramanian1, Rui Tang1, Zunming Zhang1

  • 1Department of Electrical and Computer Engineering, University of California San Diego, La Jolla, CA, 92093, USA.

Scientific Reports
|July 1, 2022
PubMed
Summary

3D imaging flow cytometry identified key cell changes in non-alcoholic steatohepatitis (NASH). This advanced technique revealed cellular differences in hepatic stellate cells (HSCs) and liver endothelial cells (LECs) during disease progression.

Related Concept Videos